Literature DB >> 12549867

Serum and plasma levels of FGF-2 and VEGF in healthy blood donors.

A Larsson1, E Sköldenberg, H Ericson.   

Abstract

VEGF-A and FGF-2 are two angiogenic growth factors involved in the growth and invasion of solid tumours and haematological malignancies. They are also believed to play an important role in cardiovascular and inflammatory diseases. Several studies dealing with measurement of circulating FGF-2 and VEGF have been published during the last decade. We have studied the levels of FGF-2 and VEGF-A in serum and EDTA plasma from 80 healthy blood donors. The samples were analyzed using the most widely used and commercially available ELISAkits. There was no significant effect of age on any of the assays and no effect of sex on P-FGF-2, S-VEGF-A and P-VEGF-A. Using the 97.5th percentile we obtained the following reference values: P-FGF-2 < 6.4 ng/l; S-VEGF-A < 500 ng/l; P-VEGF-A < 80 ng/l. Separate gender based reference intervals were made for S-FGF-2 as women had significantly higher S-FGF-2 values. Reference values for S-FGF-2 were <4.0 ng/l (men) and <10.8 ng/l (women).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12549867     DOI: 10.1023/a:1021588227705

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  36 in total

1.  Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling.

Authors:  Abhinav Tiwari; Anson K Abraham; John M Harrold; Anup Zutshi; Pratap Singh
Journal:  AAPS J       Date:  2016-12-21       Impact factor: 4.009

2.  A potential role for VEGF in the diagnostic approach of pleural effusions.

Authors:  Aggeliki Psatha; Demosthenes Makris; Theodora Kerenidi; Zoe Daniil; Theodoros Kiropoulos; Konstantinos Gourgoulianis
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report.

Authors:  M Isabel Lucena; Raúl J Andrade; Luis Vicioso; F Jesús González; Ketevan Pachkoria; Beatriz García-Muñoz
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

4.  Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies.

Authors:  Roxana Jalili; Joe Horecka; James R Swartz; Ronald W Davis; Henrik H J Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 5.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

6.  VEGF plasma levels in non-ruptured intracranial aneurysms.

Authors:  I Erol Sandalcioglu; Doreen Wende; Angelika Eggert; Jens P Regel; Dietmar Stolke; Helmut Wiedemayer
Journal:  Neurosurg Rev       Date:  2005-08-25       Impact factor: 3.042

7.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

8.  Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration.

Authors:  Sobha Sivaprasad
Journal:  Clin Ophthalmol       Date:  2008-06

Review 9.  Genetic dissection of platelet function in health and disease using systems biology.

Authors:  Wadie F Bahou
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-09       Impact factor: 3.722

10.  Plasma VEGF levels in breast cancer patients with and without metastases.

Authors:  J Stathopoulos; A Armakolas; G P Stathopoulos; I P Gomatos
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.